RE-BVS – Piemonte Repository

Sfoglia per AUTORE
COLOMBO B
Collezione ASL Asti

Items : 7

Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study. in Neurology and therapy / Neurol Ther. 2024 Oct;13(5):1505-1506. doi: 10.1007/s40120-024-00648-z.

2024
ASL Asti

Barbanti P; Egeo G; Proietti S; d'Onofrio F; Aurilia C; Finocchi C; Di Clemente L; Zucco M; Doretti A; Messina S; Autunno M; Ranieri A; Carnevale A; Colombo B; Filippi M; Tasillo M; Rinalduzzi S; Querzani P; Sette G; Forino L; Zoroddu F; Robotti M; Valenza A; Camarda C; Borrello L; Aguggia M; Viticchi G; Tomino C; Fiorentini G; et alii...

Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study. in Journal of neurology / J Neurol. 2024 May;271(5):2434-2443. doi: 10.1007/s00415-023-12103-4. Epub 2024 Jan 17.

2024
ASL Asti

Barbanti P; Aurilia C; Egeo G; Proietti S; D'Onofrio F; Torelli P; Aguggia M; Bertuzzo D; Finocchi C; Trimboli M; Cevoli S; Fiorentini G; Orlando B; Zucco M; Di Clemente L; Cetta I; Colombo B; di Poggio MLB; Favoni V; Grazzi L; Salerno A; Carnevale A; Robotti M; Frediani F; Altamura C; Filippi M; Vernieri F; Bonassi S;

Correction to: Ultra-late response (>?24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study. in Journal of neurology / J Neurol. 2024 May;271(5):2444-2445. doi: 10.1007/s00415-024-12287-3.

2024
ASL Asti

Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study. in Neurology and therapy / Neurol Ther. 2024 Jun;13(3):611-624. doi: 10.1007/s40120-024-00591-z. Epub 2024 Mar 7.

2024
ASL Asti

Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study. in The journal of headache and pain / J Headache Pain. 2023 Mar 23;24(1):30. doi: 10.1186/s10194-023-01561-w.

2023
ASL Asti

Barbanti P; Egeo G; Aurilia C; Torelli P; Finocchi C; d'Onofrio F; d'Onofrio L; Rao R; Messina S; Di Clemente L; Ranieri A; Autunno M; Sette G; Colombo B; Carnevale A; Aguggia M; Tasillo M; Zoroddu F; Frediani F; Filippi M; Tomino C; Proietti S; Bonassi S;

Stress Echocardiography in Italian Echocardiographic Laboratories: A Survey of the Italian Society of Echocardiography and Cardiovascular Imaging. in Journal of cardiovascular echography / J Cardiovasc Echogr. 2023 Jul-Sep;33(3):125-132. doi: 10.4103/jcecho.jcecho_48_23. Epub 2023 Nov 20.

2023
ASL Asti
AOU Alessandria
ASL Cuneo 1
ASL Città di Torino
ASL Vercelli
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Zugaro A; Zito C; Villari B; Zampi G; Zannoni J; Vermi AC; Venezia A; Varasano V; Vancheri F; Tusa M; Tedesco G; Tinto M; Torzillo D; Totaro A; Triolo OF; Troisi F; Tchana B; Tavarozzi I; Tassone EJ; Tarquinio N; Strangio A; Surace FC; Tamborini G; Stefani L; Scorza A; Scozzafava A; Serafini F; Serra W; Severino S; et alii...

Organization and Activity of Italian Echocardiographic Laboratories: A Survey of the Italian Society of Echocardiography and Cardiovascular Imaging. in Journal of cardiovascular echography / J Cardiovasc Echogr. 2023 Jan-Mar;33(1):1-9. doi: 10.4103/jcecho.jcecho_16_23. Epub 2023 May 29.

2023
ASL Asti
AOU Alessandria
ASL Cuneo 1
ASL Città di Torino
ASL Vercelli
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Carerj S; Villari B; Zampi G; Zannoni J; Zito C; Zugaro A; Di Bella G; Vermi AC; Venezia A; Varasano V; Vancheri F; Totaro A; Tusa M; Troisi F; Triolo OF; Tchana B; Tedesco G; Tinto M; Torzillo D; Tassone EJ; Tavarozzi I; Tarquinio N; Surace FC; Tamborini G; Strangio A; Stefani L; Solari M; Spadaro GL; Sirico D; et alii...